logo
REDUCTION OF PRACTICE VARIABILITY
OUTCOMES/ACCOUNTABILITY/PAYBACK EXPECTATIONS WITHIN MANAGED CARE ORGANIZATIONS
HIGH-COST INTERVENTION AVOIDANCE
NEED FOR IMPROVED OR NEW DIAGNOSTIC AND PHARMACEUTICAL THERAPIES FOR LUNG CANCER
QUALITY OF CURRENT PROGRAMS FOR MANAGING LUNG CANCER